Skip to content
KT
Company

Updated:

Kuvatris Therapeutics, Inc.

Kuvatris Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001811623, and its reported...

Overview

Kuvatris Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001811623, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-11, it reported annual revenue of USD 0; net income of USD -18,289,725; total assets of USD 5,680,405 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Kuvatris Therapeutics, Inc.
Former names in filing history
PaxMedica, Inc. (2020-05-15 to 2025-06-13)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Tarrytown, NY, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001811623

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2023USD$0-$18.3M$5.7M—-$10.8M
FY2022USD$0-$14.8M$2.2M$1.9M-$6.1M

Recent SEC filings

FormFiledPeriodFiling
10-Q10-Q
8-K8-K
8-KForm 8-K
8-KForm 8-K
8-KForm 8-K
S-1—Form S-1
10-Q10-Q
8-KForm 8-K
8-KForm 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Kuvatris Therapeutics, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles